Summary
Makes Medicare cover specific blood tests to find Alzheimer's disease and similar conditions early, even before symptoms show up.
What problem does this solve?
Medicare may not cover new blood tests that can detect Alzheimer's early, making it hard for seniors to get screened. This bill requires Medicare to pay for these screening tests, helping more people find the disease sooner.
What does this bill do?
Adds Medicare coverage for dementia screening tests
Amends the Social Security Act to include 'Alzheimer’s disease and related dementias early detection screening tests' as a covered medical service under Medicare.
Reference
Text:
Section:
Sec. 2(a)(2)
Header:
Alzheimer’s disease and related dementias early detection screening tests
Defines eligible screening tests
Specifies that covered tests must be cleared or approved by the FDA and can include genomic sequencing blood tests or other equivalent tests as determined by the Secretary.
Reference
Text:
Section:
Sec. 2(a)(2)
Header:
Alzheimer’s disease and related dementias early detection screening tests
Sets a start date for coverage
States that the screening tests will be covered for individuals on or after January 1, 2028.
Who does this affect?
- Seniors on Medicare
- Individuals with a family history of dementia
- Healthcare providers
What is the real world impact?
•
Promotes early detection of Alzheimer's
Encourages early screening for Alzheimer's and related dementias by making sure Medicare pays for new blood-based tests. This can help patients and families plan for the future and manage the condition sooner.
When does this start?
The new Medicare coverage for dementia screening tests would begin on January 1, 2028.